These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8292000)

  • 1. Discerning the function of p53 by examining its molecular interactions.
    Oliner JD
    Bioessays; 1993 Nov; 15(11):703-7. PubMed ID: 8292000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53: an overview of over two decades of study.
    Cheah PL; Looi LM
    Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of mutant p53 with DNA: guilt by association.
    Kim E; Deppert W
    Oncogene; 2007 Apr; 26(15):2185-90. PubMed ID: 17401427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour suppressor genes and molecular chaperones.
    Lane DP; Midgley C; Hupp T
    Philos Trans R Soc Lond B Biol Sci; 1993 Mar; 339(1289):369-72; discussion 372-3. PubMed ID: 8493291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
    Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
    Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53: an oncogenic transcription factor.
    Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
    Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel DNA binding of p53 mutants and their role in transcriptional activation.
    Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB
    Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK; Liu TJ; Frederick MJ; Clayman GL
    Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Stat3 in regulating p53 expression and function.
    Niu G; Wright KL; Ma Y; Wright GM; Huang M; Irby R; Briggs J; Karras J; Cress WD; Pardoll D; Jove R; Chen J; Yu H
    Mol Cell Biol; 2005 Sep; 25(17):7432-40. PubMed ID: 16107692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations.
    Léveillard T; Andera L; Bissonnette N; Schaeffer L; Bracco L; Egly JM; Wasylyk B
    EMBO J; 1996 Apr; 15(7):1615-24. PubMed ID: 8612585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53.
    Mori T; Anazawa Y; Iiizumi M; Fukuda S; Nakamura Y; Arakawa H
    Oncogene; 2002 Apr; 21(18):2914-8. PubMed ID: 11973653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To die or not to die: how does p53 decide?
    Slee EA; O'Connor DJ; Lu X
    Oncogene; 2004 Apr; 23(16):2809-18. PubMed ID: 15077144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
    Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
    Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activities of mutant p53: when mutations are more than a loss.
    Kim E; Deppert W
    J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.